[571]
Intraoperative ultrasonographic detection of occult liver ...
[22,4 KB]
From [www.springerlink.com] Last viewed: 16.04.2005
Clinical: Pancreatic Cancer
250
Pancreatic Cancer -Associated Diabetes is Correlated
with Increased Liver Nitric Oxide (NO)
D. Basso, P. Fogar
1
, C. Bassi
3
, A. Valerio
2
, M. Abu-Hilal
3
,
S. Mazza, F. Navaglia, C.-F. Zambon, E. Greco, M. Falconi
3
,
S. Pedrazzoli
1
, M. Plebani
Dept. of Laboratory Medicine,
1
Dept. of Medical and Surgical
Sciences,
2
Clin. and Experimental Medicine, Padova;
3
Dept of Surgery and Gastroenterology, Pancreatic Unit,
Verona, Italy
Background: In pancreatic cancer -associated diabetes mellitus (PC-DM) an altered
liver and muscle glucose metabolism occurs. NO modifies glucose release by isolated
hepatocytes. Our aims were to verify whether PC-DM determines ...
[572]
Are deaths from liver cancer, kidney cancer, and leukemia ...
[136,2 KB]
From [www.txstate.edu] Last viewed: 19.03.2005
[573]
XC1 Human, liver cancer cell lines
[75,1 KB]
From [www.funakoshi.co.jp] Last viewed: 19.03.2005
[574]
CS1 Human, liver cancer
[78,7 KB]
From [www.funakoshi.co.jp] Last viewed: 19.03.2005
[575]
Liver Cancer Incidence Is Growing Faster Than Incidence of Other ...
[141,6 KB]
From [www.ons.org] Last viewed: 19.03.2005
[576]
Expression of liver cancer associated gene HCCA3
[206,8 KB]
From [www.wjgnet.com] Last viewed: 19.03.2005
[577]
Survivin antisense compound inhibits proliferation and promotes ...
[184,1 KB]
From [www.wjgnet.com] Last viewed: 19.03.2005
[578]
Alternative Therapy and Abnormal Liver Function During Adjuvant ...
[85,3 KB]
From [jkms.kams.or.kr] Last viewed: 19.03.2005
[579]
LIVER CANCER
[23,0 KB]
From [www.long-beach.med.va.gov] Last viewed: 19.03.2005
[580]
Editorial Prevention of Primary Liver Cancer
From [sunzi1.lib.hku.hk] Last viewed: 19.03.2005
[581]
on the Advances in the Prevention of Liver Cancer
From [sunzi1.lib.hku.hk] Last viewed: 19.03.2005
[582]
Oral contraceptives and primary liver cancer among young women
[22,8 KB]
From [www.springerlink.com] Last viewed: 19.03.2005
[583]
Transcatheter arterial chemoembolization (TACE) in the treatment ...
[24,7 KB]
From [www.springerlink.com] Last viewed: 19.03.2005
[584]
Primary liver cancer and exposure to solvents
[23,6 KB]
From [www.springerlink.com] Last viewed: 19.03.2005
[585]
Characteristics of two cancer cell lines derived from metastatic ...
[22,6 KB]
From [www.springerlink.com] Last viewed: 19.03.2005
[586]
Sonographic diagnosis of solitary solid liver nodules in cancer ...
[22,8 KB]
From [www.springerlink.com] Last viewed: 19.03.2005
[587]
Long-term survival of patients with unresectable colorectal cancer ...
[23,8 KB]
From [www.springerlink.com] Last viewed: 19.03.2005
[588]
Molecular Mechanisms of Hepatocarcinogenesis in Transgenic Mouse ...
[21,6 KB]
From [taylorandfrancis.metapress.com] Last viewed: 19.03.2005
[589]
Ultrasound Imaging of Flow Patterns in Liver Metastases from ...
[21,6 KB]
From [taylorandfrancis.metapress.com] Last viewed: 19.03.2005
[590]
Hepatic Arterial Infusion of Paclitaxel for Liver Metastasis from ...
[21,0 KB]
From [taylorandfrancis.metapress.com] Last viewed: 19.03.2005
[591]
Positive Phase IIa Trial Results in Liver Cancer
[33,8 KB]
From [www.psivida.com] Last viewed: 04.03.2005
ASX/MEDIA RELEASE
15
th
February 2005
Positive Phase IIa Trial Results
in Liver Cancer
BrachySil
TM
trial confirms safety and tumor regression in further patients
Global nanotechnology company pSivida Limited ( NASDAQ:PSDV, ASX:PSD, Xetra:PSI ) is
pleased to announce that its trial in inoperable primary liver cancer patients continues to show
excellent results. Data from the second patient cohort of the current Phase IIa trial has further
demonstrated that BrachySil™ (32-P BioSilicon™) is safe and effective in tumor regression with
increased efficacy.
Results of the second group of 4 patients, 12 weeks after their BrachySil™ treatment, revealed an
average tumor regression by volume of 80% as determined by CT scanning. In some smaller
tumors 100% regression was observed, a level of performance not seen with other intratumoral ...
[592]
Positive Phase IIa Trial Results in Liver Cancer
[33,8 KB]
From [www.psivida.com.au] Last viewed: 04.03.2005
ASX/MEDIA RELEASE
15
th
February 2005
Positive Phase IIa Trial Results
in Liver Cancer
BrachySil
TM
trial confirms safety and tumor regression in further patients
Global nanotechnology company pSivida Limited ( NASDAQ:PSDV, ASX:PSD, Xetra:PSI ) is
pleased to announce that its trial in inoperable primary liver cancer patients continues to show
excellent results. Data from the second patient cohort of the current Phase IIa trial has further
demonstrated that BrachySil™ (32-P BioSilicon™) is safe and effective in tumor regression with
increased efficacy.
Results of the second group of 4 patients, 12 weeks after their BrachySil™ treatment, revealed an
average tumor regression by volume of 80% as determined by CT scanning. In some smaller
tumors 100% regression was observed, a level of performance not seen with other intratumoral ...
[593]
Chinese Herb Found Effective in Controlling Liver Cancer
[13,6 KB]
From [www.alternative2cancer.com] Last viewed: 04.03.2005
Chinese Herb Found Effective in Controlling Liver Cancer
The traditional Chinese herb Ganoderma lucidum is proving effective in limiting
the growth of liver cancer .
A research team headed by Yang Xinlin, a biologist from the Beijing University
of Science and Engineering, announced its finding at the 2002 International
Symposium on Frontiers of Tumor Prevention and Therapy held in Jinan, capital
city of east China's Shangdong Province.
Scientists have isolated an acid in Ganoderma lucidum and found the component is able to
"remarkably" restrain liver cancer cells from growing.
The control rate of the acid from Ganoderma lucidum on liver cancer reached 74.9%, says Xu
Jianlan, a leading member of the research team.
Scientists treated laboratory mice with liver cancer with the component called Ganoderma lucidum
acid, and found it was less poisonous and had fewer ...
[594]
Chronic Hepatitis and Primary Liver Cancer in Woodchucks... by BC ...
[235,1 KB]
From [www.ivis.org] Last viewed: 04.03.2005
In: 55th Annual Meeting of the American College of Veterinary Pathologists (ACVP) & 39th Annual
Meeting of the American Society of Clinical Pathology (ASVCP) , ACVP and ASVCP (Eds.)
Publisher: American College of Veterinary Pathologists & American Society for Veterinary Clinical Pathology,
Middleton WI, USA
Internet Publisher: Publisher: International Veterinary Information Service (www.ivis.org), Ithaca, New York,
USA.
Chronic Hepatitis and Primary Liver Cancer in Woodchucks (Marmota Monax)
Associated with Chronic Woodchuck Hepatitis Virus (Whv) Infection
(13-Nov-2004)
B. C. Tennant , W. E. Hornbuckle , C. A. Bellezza , L. A. Graham , I. A. Tochkov and J. R. Jacob
Gastrointestinal Unit, Department of Clinical Sciences, College of Veterinary Medicine, Cornell University, Ithaca, NY,
USA.
Naturally Occurring WHV Infection and Other Mammalian and Avian Hepadnaviruses
...
[595]
Benign liver lesions: implications of detection in cancer patients
[21,9 KB]
From [www.springerlink.com] Last viewed: 04.03.2005
Asian Pacific Journal of Cancer Prevention, Vol 2, 2001
117
Epidemiology of Liver Cancer in Thailand
Asian Pacific J Cancer Prev, 2 , 117-121
MINI-REVIEW
Introduction
During the last 20 years, the leading cause of death in
Thailand has changed from infectious diseases to non-
communicable diseases. These comprise diseases of heart
(including “heart failure”), malignant neoplasms, and
accidents and poisonings. Their rates have gradually
increased over the past decade.
Cancer registries document cases of cancer within a
particular region, providing information on how often
cancers occur, and on how many people survive their disease.
These data are needed for planning and monitoring cancer
control strategies and for identifying priorities in public
health.
The population – based cancer registry records all new
cases in ...
[596]
Laser induced human serum raman spectra of liver cancer and ...
From [ieeexplore.ieee.org] Last viewed: 04.03.2005
Asian Pacific Journal of Cancer Prevention, Vol 2, 2001
117
Epidemiology of Liver Cancer in Thailand
Asian Pacific J Cancer Prev, 2 , 117-121
MINI-REVIEW
Introduction
During the last 20 years, the leading cause of death in
Thailand has changed from infectious diseases to non-
communicable diseases. These comprise diseases of heart
(including “heart failure”), malignant neoplasms, and
accidents and poisonings. Their rates have gradually
increased over the past decade.
Cancer registries document cases of cancer within a
particular region, providing information on how often
cancers occur, and on how many people survive their disease.
These data are needed for planning and monitoring cancer
control strategies and for identifying priorities in public
health.
The population – based cancer registry records all new
cases in ...
[597]
Comprehensive Profiling of Liver Cancer Cell Surface Proteins ...
[74,4 KB]
From [www.purdue.edu] Last viewed: 18.02.2005
Comprehensive Profiling of Liver Cancer Cell Surface Proteins
Based on Affinity Capture
Bin Deng; Hong Wang; Qing Zhang;
Laura Beretta; Samir M Hanash
Public Health Sciences Division, Fred Hutchinson Cancer
Research Center
ABSTRACT
Comprehensive Profiling of Liver Cancer Cell Surface Proteins Based on Affinity
Capture Bin Deng, Hong Wang, Qing Zhang, Sufen Shang, Laura Beretta, Samir
M, Hanash* Public Health Sciences Division, Fred Hutchinson Research Cancer
Center, Seattle, Washington 98109 Global profiling of proteins expressed on the
cell surface could provide a better understanding of the manner in which cells
respond to a variety of signals and is a promising approach for the identification
of diagnostic and therapeutic targets. We previously developed a biotinylation
based approach for profiling cell surface proteins (Shin et al J Biol
Chem.278:7607-16, ...
[598]
30 Liver Cancer
[23,4 KB]
From [www.sesahs.nsw.gov.au] Last viewed: 18.02.2005
LIVER CANCER
Cancer Contr
ol
Cancer Control Bulletin
Issue 30 • January/February 2003
Information for GPs
LIVER CANCER
SOUTH EAST HEALTH
Hepatocellular carcinoma (HCC) and colorectal liver metastases are the most common
types of tumours in the liver treated in South Eastern Sydney.
Hepatocellular carcinoma
In Australia, HCC is a relatively rare cancer , accounting for 1.4% of cancer deaths. Males are 3 times
more likely to be diagnosed with primary liver cancer as females and 3.6 times as likely to die from the
disease. The incidence of HCC has trebled in the last 20 years, mainly due to the spread of hepatitis B
and C virus (HBV and HCV). Five-year survival has improved only marginally in that time and is currently
8% for males and 11% for females. HCC is endemic in developing countries, where three-quarters ...
[599]
LIVER CANCER
[61,7 KB]
From [www.vandenberg.af.mil] Last viewed: 18.02.2005
A
BASIC INFORMATION
DESCRIPTION
Uncontrolled growth of malignant cells in the liver .
Liver cancer may be primarily resulting from abnormal
liver or bile-duct cells, or it may result from spread of
cancer from another site (metastases). The most com-
mon sources are cancers of the rectum, colon, lung,
breast, pancreas, esophagus or skin (malignant
melanoma). Liver cancer can affect all ages, but is most
common in men over 60.
FREQUENT SIGNS AND SYMPTOMS
• Loss of appetite and weight loss.
• Tender mass in the right upper abdomen.
• Pain in the upper abdomen.
• Low fever, usually less than 101°F (38.3°C).
• Yellow eyes and skin (sometimes).
• Swollen abdomen from fluid retention (sometimes).
• Lethargy.
CAUSES
Unknown. It occurs most often in population groups
with a high incidence of viral hepatitis and other chronic
liver ...
[600]
LIVER CANCER
[61,7 KB]
From [vandenberg.af.mil] Last viewed: 18.02.2005
A
BASIC INFORMATION
DESCRIPTION
Uncontrolled growth of malignant cells in the liver .
Liver cancer may be primarily resulting from abnormal
liver or bile-duct cells, or it may result from spread of
cancer from another site (metastases). The most com-
mon sources are cancers of the rectum, colon, lung,
breast, pancreas, esophagus or skin (malignant
melanoma). Liver cancer can affect all ages, but is most
common in men over 60.
FREQUENT SIGNS AND SYMPTOMS
• Loss of appetite and weight loss.
• Tender mass in the right upper abdomen.
• Pain in the upper abdomen.
• Low fever, usually less than 101°F (38.3°C).
• Yellow eyes and skin (sometimes).
• Swollen abdomen from fluid retention (sometimes).
• Lethargy.
CAUSES
Unknown. It occurs most often in population groups
with a high incidence of viral hepatitis and other chronic
liver ...
Found 899 documents
Page 20 of 30 Pages:
<< < 15 16 17 18 19 20 21 22 23 24 25 > >>
cancers
homepage
last week